JOHNPHARMADiversified Commercial Services
Johnson Pharmacare Ltd — Cash Flow Statement
₹0.48
-4.00%
Johnson Pharmacare Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -1.91 Cr | -0.05 Cr | -0.40 Cr | 4.90 Cr | — |
| End Cash Position | 0.01 Cr | 14000.00 | 18000.00 | 0.04 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 1000.00 | — | 4.07 Cr | -5.01 Cr | — |
| Beginning Cash Position | 14000.00 | 18000.00 | 0.04 Cr | 0.23 Cr | — |
| Changes In Cash | 0.01 Cr | -4000.00 | -0.04 Cr | 4.81 Cr | — |
| Financing Cash Flow | -1.34 Cr | 0.00 | 1.30 Cr | -0.08 Cr | — |
| Interest Paid Cff | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | -1.34 Cr | 0.00 | 1.30 Cr | -0.08 Cr | — |
| Net Short Term Debt Issuance | 0.00 | 0.00 | 1.30 Cr | -0.08 Cr | — |
| Net Long Term Debt Issuance | -1.34 Cr | 0.00 | 0.00 | 0.00 | — |
| Investing Cash Flow | 3.27 Cr | 0.04 Cr | -0.94 Cr | 0.00 | — |
| Net Business Purchase And Sale | 3.27 Cr | 0.04 Cr | 8.62 Cr | 0.00 | — |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Operating Cash Flow | -1.91 Cr | -0.05 Cr | -0.40 Cr | 4.90 Cr | — |
| Taxes Refund Paid | 0.00 | 0.00 | 0.04 Cr | -0.04 Cr | — |
| Change In Working Capital | -1.33 Cr | 0.15 Cr | 0.89 Cr | 6.10 Cr | — |
| Change In Other Current Liabilities | 0.02 Cr | 0.15 Cr | -0.16 Cr | 1.13 Cr | — |
| Change In Other Current Assets | -1.35 Cr | 0.00 | 0.00 | 0.00 | — |
| Change In Inventory | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Receivables | 0.00 | 0.00 | 1.05 Cr | 4.32 Cr | — |
| Depreciation And Amortization | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operations | -0.58 Cr | -0.20 Cr | -1.33 Cr | 0.13 Cr | — |
| Issuance Of Capital Stock | — | 0.00 | 0.00 | 0.00 | — |
| Net Common Stock Issuance | — | 0.00 | 0.00 | 0.00 | — |
| Common Stock Issuance | — | 0.00 | 0.00 | 0.00 | — |
| Interest Received Cfi | — | — | 0.00 | 0.00 | — |
| Net Investment Purchase And Sale | — | — | 8.62 Cr | -1.92 Cr | 1000.00 |
| Change In Payable | — | — | — | 0.65 Cr | 0.65 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Johnson Pharmacare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.